Published in Vet Microbiol on July 01, 1994
Mycobacterium avium subsp. paratuberculosis in Veterinary Medicine. Clin Microbiol Rev (2001) 3.58
Differential changes in heat shock protein-, lipoarabinomannan-, and purified protein derivative-specific immunoglobulin G1 and G2 isotype responses during bovine Mycobacterium avium subsp. paratuberculosis infection. Infect Immun (2001) 1.50
Characterization of novel coding sequences specific to Mycobacterium avium subsp. paratuberculosis: implications for diagnosis of Johne's Disease. J Clin Microbiol (2004) 1.26
Rapid expression of Mycobacterium avium subsp. paratuberculosis recombinant proteins for antigen discovery. Clin Vaccine Immunol (2006) 0.84
One hundred questions of importance to the conservation of global biological diversity. Conserv Biol (2009) 3.95
The role of biostatistics in the prevention, detection and treatment of fraud in clinical trials. Stat Med (1999) 3.53
Identification of two groups of Mycobacterium paratuberculosis strains by restriction endonuclease analysis and DNA hybridization. J Clin Microbiol (1990) 2.65
Immunological responses and protection against Mycobacterium bovis in calves vaccinated with a low dose of BCG. Vaccine (1995) 2.37
Mutation of the principal sigma factor causes loss of virulence in a strain of the Mycobacterium tuberculosis complex. Proc Natl Acad Sci U S A (1995) 2.17
An esat6 knockout mutant of Mycobacterium bovis produced by homologous recombination will contribute to the development of a live tuberculosis vaccine. Tuber Lung Dis (2000) 2.06
Effect of inhA and katG on isoniazid resistance and virulence of Mycobacterium bovis. Mol Microbiol (1995) 1.95
Evidence for a complex regulatory array in the first intron of the human adenosine deaminase gene. Genes Dev (1989) 1.93
Ovine dermatophilosis in young sheep associated with the grazing of Brassica spp. crops. N Z Vet J (1985) 1.92
Restriction endonuclease analysis of Brucella ovis and other Brucella species. Vet Microbiol (1985) 1.83
The pharmaceutical industry and health reform: lessons from Europe. Health Aff (Millwood) (1994) 1.81
Oral vaccination reduces the incidence of tuberculosis in free-living brushtail possums. Proc Biol Sci (2009) 1.75
A systematic review of the staging performance of endoscopic ultrasound in gastro-oesophageal carcinoma. Gut (2001) 1.72
Prevalence of anthelmintic resistance on sheep farms in New Zealand. N Z Vet J (2006) 1.62
Antisense RNA to ahpC, an oxidative stress defence gene involved in isoniazid resistance, indicates that AhpC of Mycobacterium bovis has virulence properties. Microbiology (1998) 1.50
Desk top analysers in general medical practice: how useful are they? Med Lab Sci (1990) 1.48
Cost-effectiveness of oral ibandronate compared with intravenous (i.v.) zoledronic acid or i.v. generic pamidronate in breast cancer patients with metastatic bone disease undergoing i.v. chemotherapy. Support Care Cancer (2005) 1.48
Restriction endonuclease analysis of various strains of Mycobacterium paratuberculosis isolated from cattle. Am J Vet Res (1986) 1.47
Randomised controlled trial comparing endometrial resection with abdominal hysterectomy for the surgical treatment of menorrhagia. Br J Obstet Gynaecol (1993) 1.47
Association between natural scrapie and PrP genotype in a flock of Suffolk sheep in Scotland. Vet Rec (1997) 1.46
Advances in understanding disease epidemiology and implications for control and eradication of tuberculosis in livestock: the experience from New Zealand. Vet Microbiol (2005) 1.45
Systematic review of utilities in abdominal aortic aneurysm. Eur J Vasc Endovasc Surg (2008) 1.42
Inefficacy of ivermectin against Cooperia spp. Infection in cattle. N Z Vet J (1994) 1.41
Guidance on the use of PrP genotyping as an aid to the control of clinical scrapie. Scrapie Information Group. Vet Rec (1998) 1.40
Campylobacter fetus fetus abortions in vaccinated ewes. N Z Vet J (2000) 1.40
Developing guidance for budget impact analysis. Pharmacoeconomics (2001) 1.40
Typing of Campylobacter fetus fetus isolated from sheep abortions in New Zealand. N Z Vet J (1985) 1.39
Observations on three outbreaks of Leptospira interrogans serovar pomona infection in lambs. N Z Vet J (1994) 1.38
In vivo activity and in vitro specificity of CD4+ Th1 and Th2 cells derived from the spleens of diabetic NOD mice. J Clin Invest (1995) 1.36
Transcription activation at class II CRP-dependent promoters: the role of different activating regions. Nucleic Acids Res (1997) 1.34
Restriction endonuclease analysis of members of the Mycobacterium avium-M. intracellulare-M. scrofulaceum serocomplex. J Clin Microbiol (1987) 1.34
Q fever is absent from New Zealand. Int J Epidemiol (1993) 1.29
Use of ESAT-6 in the interferon-gamma test for diagnosis of bovine tuberculosis following skin testing. Vet Microbiol (2001) 1.28
Initial results of screening of nondiabetic organ donors for expression of islet autoantibodies. J Clin Endocrinol Metab (2006) 1.27
A comparison of the costs and survival of hospital-admitted stroke patients across Europe. Stroke (2001) 1.27
Bovine paratuberculosis II. A comparison of fecal culture and the antibody response. Can J Comp Med (1980) 1.26
Health information Websites: characteristics of US users by race and ethnicity. J Telemed Telecare (2007) 1.26
Comparison of polymerase chain reaction tests and faecal culture for detecting Mycobacterium paratuberculosis in bovine faeces. Vet Microbiol (1993) 1.25
Typing of Mycobacterium bovis isolates from cattle and other animals in the same locality. N Z Vet J (1988) 1.23
Mycobacterium bovis infection in wildlife in New Zealand. Tuberculosis (Edinb) (2001) 1.23
Use of four DNA insertion sequences to characterize strains of the Mycobacterium avium complex isolated from animals. Mol Cell Probes (1997) 1.23
Mycobacterial diseases of deer. N Z Vet J (2004) 1.21
Detection of Mycobacterium bovis in tissues by polymerase chain reaction. Vet Microbiol (1995) 1.19
Campylobacter infections in normal and diarrhoeic dogs. Vet Rec (1979) 1.15
Use of mycobacterial peptides and recombinant proteins for the diagnosis of bovine tuberculosis in skin test-positive cattle. Vet Rec (2003) 1.15
Multiple resistance to ivermectin and oxfendazole in Cooperia species of cattle in New Zealand. Vet Rec (1995) 1.14
Nutrition economics - characterising the economic and health impact of nutrition. Br J Nutr (2010) 1.14
Calcium hydroxyapatite promotes mitogenesis and matrix metalloproteinase expression in human breast cancer cell lines. Mol Carcinog (2001) 1.14
Effect of turbulent-flow pasteurization on survival of Mycobacterium avium subsp. paratuberculosis added to raw milk. Appl Environ Microbiol (2001) 1.13
European School of Oncology Advisory report to the Commission of the European Communities for the "Europe Against Cancer Programme" cost-effectiveness in cancer care. Eur J Cancer (1995) 1.12
Cost effectiveness of treatment options in advanced breast cancer in the UK. Pharmacoeconomics (2001) 1.11
Bovine paratuberculosis I. A herd study using complement fixation and intradermal tests. Can J Comp Med (1980) 1.11
An economic evaluation of transcervical endometrial resection versus abdominal hysterectomy for the treatment of menorrhagia. Br J Obstet Gynaecol (1993) 1.09
Salmonellosis in ram hoggets following prophylactic zinc dosing. N Z Vet J (1985) 1.09
The role of liver Cu kinetics in the depletion of reserves of Cu in dairy cows fed a Cu-deficient diet. N Z Vet J (2012) 1.09
16-aryloxyprostaglandins: a new class of potent luteolytic agent. Prostaglandins (1974) 1.08
Advances in ante-mortem diagnosis of tuberculosis in cattle. N Z Vet J (2009) 1.08
Humoral immune response against lipopolysaccharide and cytoplasmic proteins of Brucella abortus in cattle vaccinated with B. abortus S19 or experimentally infected with Yersinia enterocolitica serotype 0:9. Clin Diagn Lab Immunol (1996) 1.07
Toward eradication: the effect of Mycobacterium bovis infection in wildlife on the evolution and future direction of bovine tuberculosis management in New Zealand. N Z Vet J (2015) 1.07
Minor nucleotide substitutions in the omp31 gene of Brucella ovis result in antigenic differences in the major outer membrane protein that it encodes compared to those of the other Brucella species. Infect Immun (2001) 1.06
Cost-effectiveness analysis comparing epidural, patient-controlled intravenous morphine, and continuous wound infiltration for postoperative pain management after open abdominal surgery. Br J Anaesth (2012) 1.05
Ovine ceroid-lipofuscinosis: a model of Batten's disease. Neuropathol Appl Neurobiol (1980) 1.03
A review of infection of wildlife hosts with Mycobacterium bovis and the diagnostic difficulties of the 'no visible lesion' presentation. N Z Vet J (2009) 1.03
Differential splicing of the IA-2 mRNA in pancreas and lymphoid organs as a permissive genetic mechanism for autoimmunity against the IA-2 type 1 diabetes autoantigen. Diabetes (2001) 1.03
Immune responses induced in cattle by virulent and attenuated Mycobacterium bovis strains: correlation of delayed-type hypersensitivity with ability of strains to grow in macrophages. Infect Immun (1999) 1.02
Cost effectiveness of drotrecogin alfa (activated) for the treatment of severe sepsis in the United Kingdom. Anaesthesia (2005) 1.02
Prevalence of pathogenic Leptospira spp. in sheep in a sheep-only abattoir in New Zealand. N Z Vet J (2008) 1.02
Economic evaluation of healthcare: a half-way technology. Health Econ (1994) 1.01
Genetic association of zinc transporter 8 (ZnT8) autoantibodies in type 1 diabetes cases. Diabetologia (2012) 1.00
Cost-utility model comparing docetaxel and paclitaxel in advanced breast cancer patients. Anticancer Drugs (1998) 1.00
Serological crossreactivity between Brucella abortus and Yersinia enterocolitica 0:9 I immunoblot analysis of the antibody response to Brucella protein antigens in bovine brucellosis. Vet Microbiol (1995) 0.99
Isolation and sequence analysis of cDNA for rat carboxypeptidase E [EC 3.4.17.10], a neuropeptide processing enzyme. Mol Endocrinol (1989) 0.98
Prevalence of anthelmintic resistance on 62 beef cattle farms in the North Island of New Zealand. N Z Vet J (2006) 0.97
Vaccination of cattle with Mycobacterium bovis culture filtrate proteins and interleukin-2 for protection against bovine tuberculosis. Infect Immun (2000) 0.97
Treatment pathways, resource use and costs in the management of small cell lung cancer. Thorax (2001) 0.97
The identification of bias in studies of the diagnostic performance of imaging modalities. Br J Radiol (1997) 0.97
Bovine tuberculosis in Swedish deer farms: epidemiological investigations and tracing using restriction fragment analysis. Vet Rec (1995) 0.96
Oral delivery of lipid-encapsulated Mycobacterium bovis BCG extends survival of the bacillus in vivo and induces a long-term protective immune response against tuberculosis. Vaccine (2005) 0.96
DNA restriction fragment typing of Mycobacterium bovis isolates from cattle and badgers in Ireland. Vet Rec (1994) 0.95
Identifying studies for systematic reviews. An example from medical imaging. Int J Technol Assess Health Care (2000) 0.95
Experimental Mycobacterium bovis infection of cattle: effect of dose of M. bovis and pregnancy on immune responses and distribution of lesions. N Z Vet J (1994) 0.95
A study of the environmental survival of Mycobacterium bovis on a farm in New Zealand. N Z Vet J (1995) 0.95
Isolation, physicochemical properties, and the macromolecular composition of the vitelline and fertilization envelopes from Xenopus laevis eggs. Biochemistry (1976) 0.95
Investigation of Mycobacterium paratuberculosis in sheep by faecal culture, DNA characterisation and the polymerase chain reaction. Vet Rec (1993) 0.93
Construction and screening of Mycobacterium paratuberculosis insertional mutant libraries. Arch Microbiol (2000) 0.93
Development of integrated surveillance systems for the management of tuberculosis in New Zealand wildlife. N Z Vet J (2015) 0.92
Age susceptibility of red deer (Cervus elaphus) to paratuberculosis. Vet Microbiol (2009) 0.92
Demonstration of polymorphism among Brucella ovis field isolates by pulsed-field gel electrophoresis. Vet Microbiol (2005) 0.92
One year comparison of costs of coronary surgery versus percutaneous coronary intervention in the stent or surgery trial. Heart (2004) 0.92
Oral mucosal Langerhans' cells as target, effector and vector in HIV infection. J Oral Pathol Med (2000) 0.92
A multiplex allele specific polymerase chain reaction (MAS-PCR) on the dihydrofolate reductase gene for the detection of Cryptosporidium parvum genotypes 1 and 2. Parasitology (2002) 0.91
Workshop Report: concepts and methods in the economics of nutrition--gateways to better economic evaluation of nutrition interventions. Br J Nutr (2012) 0.91